Lack of Clinically Relevant Drug–Drug Interaction Between Empagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, and Verapamil, Ramipril, or Digoxin in Healthy Volunteers
2013 ◽
Vol 35
(3)
◽
pp. 226-235
◽
Keyword(s):
2012 ◽
Vol 15
(4)
◽
pp. 316-323
◽
Keyword(s):
2018 ◽
Vol 74
(12)
◽
pp. 1605-1613
◽
Keyword(s):
2012 ◽
Vol 86
(3)
◽
pp. 489-495
◽
2019 ◽
Vol 106
(5)
◽
pp. 1093-1098
◽
2013 ◽
Vol 68
(6)
◽
pp. 1415-1422
◽
2017 ◽
Vol 7
(2)
◽
pp. 143-150
◽